MCI Onehealth Technologies Inc.
MCIOF
Other OTC0.55
USD
-0.01
- -
Return %
Stock
S&P500
1Y
-0.20
26.57
3Y
-43.48
76.60
5Y
-43.48
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Alexander Julian Dobranowski
- Full Time Employees
- 340
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 4881 Yonge Street Toronto ON Canada M2N 5X3
- IPO Date
- Dec 21, 2021
- Website
- mcionehealth.com
- Similar Companies
- Business
- MCI Onehealth Technologies Inc. (OTC: MCIOF), now operating as HEALWELL AI Inc., is a healthcare technology company focused on AI and data science for preventative care, developing and commercializing clinical decision support systems to detect rare, complex, and chronic diseases early. The company offers AI-driven healthcare analytics and insights; technology-enabled chronic disease screening tools; electronic health record software and data management services; pulmonary function testing lab services; clinical research services; medical consultation services; primary and specialty healthcare services; brightOS data analytics platform for visualizing de-identified clinical data and machine learning algorithms; and Onehealth Assistant, an AI-powered chatbot guiding patients to appropriate care pathways. Founded in 1986 and headquartered in Toronto, Ontario, Canada, it previously operated primary care clinics across Canada serving over 850,000 patients annually and occupational health services for corporate customers, with geographic operations now emphasizing Canada, New Zealand, Australia, and the United Kingdom through segments including clinical research and patient services, AI and data sciences, and healthcare software. In October 2023, the company rebranded from MCI Onehealth Technologies Inc. to HEALWELL AI Inc. following a strategic transaction with WELL Health Technologies Corp., which included selling Ontario clinical assets generating over $21 million in annual revenue, raising $10 million via convertible debenture units led by WELL, forming a strategic alliance for AI technology deployment and clinic network access, and granting WELL a call option for a controlling interest. More recently, in October 2024, it partnered with MDClone to leverage real-world patient data for clinical insights, synthetic data generation, and accelerated healthcare research using MDClone's technology for data organization and protection. In September 2025, HEALWELL AI reported Q2 2025 earnings and acquired the remaining 49% stake in a key asset, while anticipating regulatory scrutiny related to WELL Health's controlling interest acquisition.